MEDBOX | Toolbox Inactivated COVID-19 Vaccines

NEW

World Health Organization WHO (2021) C_WHO

orientations provisoires, 7 mai 2021

Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines,

Source: https://apps.who.int/iris/bitstream/hand

NEW

World Health Organization WHO (2021) C_WHO

временное руководство, 7 мая 2021 г.

Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines,

Source: https://apps.who.int/iris/bitstream/hand

NEW

World Health Organization WHO (2021) C_WHO

1 June 2021, These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below

Tags: Immunization, vaccine, COVID-19, SARS-CoV-2, sinovac,

Source: https://apps.who.int/iris/rest/bitstream

Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19

World Health Organization WHO (2021) C_WHO

1 June 2021 This background document on the Sinovac-CoronaVac vaccine was prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of Experts (SAGE) on Immunization to inform SAGE deliberations. It contains the evidence summary which was considered by SAGE and served as the foundation for the WHO Interim recommendations referenced below. This background document was developed to inform the initial recommendation-making process. It is not updated on a regular basis. For the latest Grade and ETR tables see link below

Tags: sinovac, COVID-19, vaccine, SARS-CoV-2,

Source: https://apps.who.int/iris/rest/bitstream

Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables

World Health Organization WHO (2021) C_WHO

1 June 2021

Tags: sinovac, COVID-19, vaccine, SARS-CoV-2,

Source: https://apps.who.int/iris/rest/bitstream

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm (Arabic)

World Health Organization WHO (2021) C_WHO

Interim guidance, 7 May 2021

Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines,

Source: https://apps.who.int/iris/bitstream/hand

Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm, 7 May 2021

World Health Organization WHO (2021) C_WHO

7 May 2021

Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines,

Source: https://apps.who.int/iris/rest/bitstream

Background document on the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm, 7 May 2021

World Health Organization WHO (2021) C_WHO

7 May 2021

Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines,

Source: https://apps.who.int/iris/rest/bitstream

	Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé BIBP mis au point par China National Biotec Group (‎CNBG)‎, Sinopharm NEW World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX orientations provisoires, 7 mai 2021 Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines, Source: https://apps.who.int/iris/bitstream/hand
	Предварительные рекомендации по применению инактивированной вакцины BIBP против Covid-19 разработанной China National Biotec Group (‎CNBG)‎, Sinopharm NEW World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX временное руководство, 7 мая 2021 г. Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines, Source: https://apps.who.int/iris/bitstream/hand
	Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac NEW World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 1 June 2021, These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below Tags: Immunization, vaccine, COVID-19, SARS-CoV-2, sinovac, Source: https://apps.who.int/iris/rest/bitstream
	Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19 World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 1 June 2021 This background document on the Sinovac-CoronaVac vaccine was prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of Experts (SAGE) on Immunization to inform SAGE deliberations. It contains the evidence summary which was considered by SAGE and served as the foundation for the WHO Interim recommendations referenced below. This background document was developed to inform the initial recommendation-making process. It is not updated on a regular basis. For the latest Grade and ETR tables see link below Tags: sinovac, COVID-19, vaccine, SARS-CoV-2, Source: https://apps.who.int/iris/rest/bitstream
	Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 1 June 2021 Tags: sinovac, COVID-19, vaccine, SARS-CoV-2, Source: https://apps.who.int/iris/rest/bitstream
	Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm (Arabic) World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Interim guidance, 7 May 2021 Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines, Source: https://apps.who.int/iris/bitstream/hand
	Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm, 7 May 2021 World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 7 May 2021 Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines, Source: https://apps.who.int/iris/rest/bitstream
	Background document on the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm, 7 May 2021 World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 7 May 2021 Tags: sinopharm, vaccine, COVID-19, SARS-CoV-2, vaccine candidates, inactivated vaccines, Source: https://apps.who.int/iris/rest/bitstream

About MEDBOX

MEDBOX Video Series